EKIMAS Corporation
EKIMAS Corporation Fundamental Analysis
EKIMAS Corporation (ASNB) shows weak financial fundamentals with a PE ratio of -3.47, profit margin of 0.00%, and ROE of -7.18%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -16.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ASNB's fundamental strength across five key dimensions:
Efficiency Score
WeakASNB struggles to generate sufficient returns from assets.
Valuation Score
ExcellentASNB trades at attractive valuation levels.
Growth Score
WeakASNB faces weak or negative growth trends.
Financial Health Score
ModerateASNB shows balanced financial health with some risks.
Profitability Score
WeakASNB struggles to sustain strong margins.
Key Financial Metrics
Is ASNB Expensive or Cheap?
P/E Ratio
ASNB trades at -3.47 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ASNB's PEG of -0.06 indicates potential undervaluation.
Price to Book
The market values EKIMAS Corporation at 0.24 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -1.77 times EBITDA. This is generally considered low.
How Well Does ASNB Make Money?
Net Profit Margin
For every $100 in sales, EKIMAS Corporation keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-7.18 in profit for every $100 of shareholder equity.
ROA
EKIMAS Corporation generates $-6.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-19.96 in free cash annually.
FCF Yield
ASNB converts -76.92% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-3.47
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.06
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.24
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.71
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.07
vs 25 benchmark
ROA
Return on assets percentage
-0.06
vs 25 benchmark
ROCE
Return on capital employed
-0.05
vs 25 benchmark
How ASNB Stacks Against Its Sector Peers
| Metric | ASNB Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -3.47 | 19.09 | Better (Cheaper) |
| ROE | -7.18% | 842.00% | Weak |
| Net Margin | 0.00% | 3730.00% | Weak |
| Debt/Equity | 0.00 | 0.89 | Strong (Low Leverage) |
| Current Ratio | 0.71 | 660.25 | Weak Liquidity |
| ROA | -6.00% | -24785.00% (disorted) | Weak |
ASNB outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews EKIMAS Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical